Gonorrhea
Researchers from Australia and the United States describe findings in gonorrhea studies
Published in TB and Outbreaks Week, July 11th, 2006
Study 1: Prolyliminopeptidase-negative Neisseria gonorrhoeae strains in Sydney, Australia followed an epidemic growth curve from 2002-2005.
"Recent studies have demonstrated a wide geographic circulation of isolates of Neisseria gonorrhoeae that fail to produce prolyliminopeptidase (PIP). Tests based on the production of this enzyme are important elements of a number of identification systems for gonococci," researchers in Australia report.
According to scientists, "We documented the appearance, expansion, and contraction of subtypes...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Botulism Outbreaks
Botulism outbreak caused by roasted canned mushrooms in Turkey - Ebola Virus Detection
Ebola virus antibodies detected in oral fluid when RT-PCR is positive - Escherichia Coli
Shiga-toxigenic Escherichia coli O157 isolated from agricultural fair livestock - HIV/AIDS & Tuberculosis
Nearly half of new TB cases are acquired from HIV-infected household contacts in Malawi - Mycobacterium Tuberculosis
MTB mutT gene polymorphisms are characteristic, unique to Beijing phylogenetic lineage - Avian Influenza
Bird flu vaccine could be basis for life-saving stockpile - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
